PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 11 filers reported holding PTC THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 8,067,000 | $8,071,000 | 7.78% |
| DeepCurrents Investment Group LLC | 5,000,000 | $4,975,000 | 0.62% |
| WOLVERINE ASSET MANAGEMENT LLC | 27,439,000 | $27,337,000 | 0.33% |
| CSS LLC/IL | 3,000,000 | $2,993,000 | 0.20% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,130,000 | $23,602,000 | 0.17% |
| Allianz Asset Management GmbH | 30,570,000 | $30,097,000 | 0.03% |
| CREDIT SUISSE AG/ | 12,105,000 | $12,029,000 | 0.01% |
| JANUS HENDERSON GROUP PLC | 15,498,000 | $15,401,000 | 0.01% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 11,300,000 | $11,200,153,000 | 0.01% |
| AMERIPRISE FINANCIAL INC | 12,700,000 | $12,621,000 | 0.01% |